Exercise tolerance after beta blockade in recent cardiac transplant recipients

Area of Science:

• Cardiology
• Transplantation Medicine
• Exercise Physiology

Background:

• Cardiac transplant recipients often exhibit reduced exercise capacity due to altered sympathoadrenal responses.
• There is ongoing debate regarding the use of beta-blockers post-heart transplantation.
• The dependence of the transplanted heart on catecholamines influences exercise response.

Purpose of the Study:

• To evaluate the impact of early oral atenolol administration on exercise tolerance in cardiac transplant recipients.
• To investigate the safety and efficacy of beta-blockade in this specific patient population.

Main Methods:

• Eighteen stable cardiac transplant recipients underwent symptom-limited maximal exercise testing.
• Exercise tests were performed before and two hours after a single oral dose of atenolol.
• Key parameters including heart rate, blood pressure, exercise duration, and metabolic equivalents (METS) were recorded.

Main Results:

• Atenolol significantly reduced resting and peak heart rates but did not significantly alter exercise duration or METS.
• No significant difference was observed in exercise time or estimated oxygen consumption with atenolol.
• Patients did not report increased fatigue after beta-blockade.

Conclusions:

• Early administration of atenolol demonstrates minimal adverse effects on exercise tolerance in recently transplanted cardiac patients.
• Atenolol appears to be a safe option for managing exercise capacity in this population.